Apple’s $10 Million Grant Helps COPAN Diagnostics Increase Production of COVID-19 Sample Collection and Transport Products by 4,000%

SourceDARK Daily
Date Published03/15/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Copan Diagnostics, Inc.
Parent companyCOPAN Group
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):250
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:In-house
Capital investment ($):10
Country(ies) from which reshored:Italy
City reshored to:Carlsbad
State(s) reshored to:CA
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredSARS-CoV-2 sample collection and transport kits
What domestic positive factors made reshoring more attractive?Higher productivity, Lead time/Time to market, Skilled workforce availability/training, Other, Covid-19, import replacement
Find Reshoring Articles